India DCGI Proposes Prescription-Only For 92 Antibiotics, TB Drugs
This article was originally published in PharmAsia News
India's health authorities plan to restrict 92 antibiotics and tuberculosis drugs to prescription only, ending over-the-counter sales.
You may also be interested in...
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.
Butterfly Network is disseminating the lessons from China and Italy about the poential value of lung ultrasound in the management of COVID-19 patients with respiratory disease.
Japan approval for BTK inhibitor marks new indication but in a small niche market, while another clearance may help extend Latuda's commercial life.